EC
HRMY icon

EntryPoint Capital’s Harmony Biosciences HRMY Stock Holding History

EntryPoint Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$680K Buy
24,264
+16,578
+216% +$544K 0.2% 150
2025
Q4 		$288K Buy
7,686
+107
+1% +$3.52K 0.11% 378
2025
Q3 		$209K Sell
7,579
-4,717
-38% -$162K 0.08% 537
2025
Q2 		$389K Sell
12,296
-474
-4% -$15.2K 0.19% 176
2025
Q1 		$424K Sell
12,770
-19,314
-60% -$692K 0.19% 162
2024
Q4 		$1.1M Buy
+32,084
New +$1.1M 0.46% 2
2024
Q3 		– Sell
-4,271
Closed -$129K – 847
2024
Q2 		$129K Buy
4,271
+363
+9% +$10.9K 0.19% 195
2024
Q1 		$131K Sell
3,908
-941
-19% -$30.2K 0.12% 286
2023
Q4 		$157K Buy
+4,849
New +$135K 0.15% 169

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return